NCT02689505View on ClinicalTrials.gov

Weekly BI 836880 in Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

April 4, 2016

Primary Completion Date

July 31, 2019

Study Completion Date

July 31, 2019

Conditions
Neoplasms
Interventions
DRUG

BI 836880

Solution for intravenous infusion

Trial Locations (2)

21079

CTR Georges-François Leclerc, Dijon

08035

Hospital Vall d'Hebron, Barcelona

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY